1.Kim ES. (2016) Olmutinib: First Global Approval.. Drugs, 76 (11):(1153-7). [PMID:27357069]
2.Park JK, Byun JY, Park JA, Kim YY, Lee YJ, Oh JI, Jang SY, Kim YH, Song YW, Son J et al.. (2015) HM71224, a novel Bruton's tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis.. Arthritis Res Ther, 18 (3):(91). [PMID:27090981]
3.Park K, Lee JS, Han JY, Lee KH, Kim JH, Cho EK, Cho JY, Min YJ, Kim JS, Kim DW. (2016) 1300: Efficacy and safety of BI 1482694 (HM61713), an EGFR mutant-specific inhibitor, in T790M-positive NSCLC at the recommended phase II dose.. J Thorac Oncol, 11 (4 Suppl):(S113). [PMID:27198272]
4.Park K, Han JY, Kim DW, Bazhenova LA, Ou SH, Pang YK, Hin HS, Juan O, Son J, Jänne P. (2016) 190TiP: ELUXA 1: Phase II study of BI 1482694 (HM61713) in patients (pts) with T790M-positive non-small cell lung cancer (NSCLC) after treatment with an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI).. J Thorac Oncol, 11 (4 Suppl):(S139). [PMID:27198328]
5.Russo A, Franchina T, Ricciardi GRR, Smiroldo V, Picciotto M, Zanghì M, Rolfo C, Adamo V. (2017) Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going.. Crit Rev Oncol Hematol, 117 (3):(38-47). [PMID:28807234]
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
C2212122